Rebeccah Moraa Ayako

Ms. Rebeccah Moraa Ayako

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2024 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
RARebeccah Moraa Ayako
Rebeccah Moraa Ayako
KPKirtika Patel
Kirtika Patel
INIsaac Ndede
Isaac Ndede
JNJohan Nordgren
Johan Nordgren
MLMarie Larrson
Marie Larrson
SMSimeon K. Mining
Simeon K. Mining
Introduction: There are few accurate prognostic indications of the illness's development and severity for COVID‐19, despite certain biomarkers having been investigated. The unexpected nature of COVID‐19's course, which can quickly progress from asymptomatic to life‐threatening symptoms, lies at the heart of the disease's intricacy. Predicting SARS‐CoV‐2 pathogenicity through laboratory biomarkers and as such, identifying the patients’ illness severity at the time of their initial admission would be crucial in improving patient care. In this study, we sought to evaluate the potential of hematological, biochemical, and inflammatory biomarkers in predicting the course of COVID‐19 at a tertiary hospital in western Kenya.Methods: This cross‐sectional study involved 48 COVID‐19 patients (16 asymptomatic; 16 moderate symptomatic; and 16 severe symptomatic) and 48 age‐sex‐matched COVID‐19‐negative clients attending the Moi Teaching and Referral Hospital, Kenya. Demographic information, self‐reported chronic illnesses, symptoms, and laboratory results were collected at recruitment.Results: Significantly, the severity of COVID‐19 was associated with; hemoglobin (p < 0.0001), white blood cells (p = 0.0022), hematocrit (p < 0.0001), blood urea nitrogen (p = 0.01), blood sodium (p = 0.0002), potassium (p = 0.0483), C‐reactive protein (p = 0.0002), and Lactate Dehydrogenase (p < 0.0001). Regression analysis of CRP revealed a strong positive correlation (p = 0.0006) whereas LDH revealed a weak positive correlation (p < 0.0001) with COVID‐19 disease severity. Discriminative accuracy was highest when asymptomatic was compared to severe COVID‐19 for CRP and LDH (AUC: 0.8867, 95% CI: 0.7532–1.000) and (AUC: 1.000, 95% CI: 1.000–1.000) respectively.Conclusion: The hematological indices, inflammatory and biochemical biomarkers studied have the potential to predict the course of COVID‐19. These parameters may be useful in helping design appropriate care for COVID‐19 patients.

30 January 2024
Verified
Preprint
Open access
PDF file
RARebeccah Moraa Ayako
Rebeccah Moraa Ayako
KPKirtika Patel
Kirtika Patel
INIsaac Ndede
Isaac Ndede
JNJohan Nordgren
Johan Nordgren
MLMarie Larsson
Marie Larsson
SMSimeon K. Mining
Simeon K. Mining
There are few accurate prognostic indications of the illness’s development and severity for COVID-19, despite certain biomarkers having been investigated. The unexpected nature of COVID-19’s course, which can quickly progress from asymptomatic to severe disease, lies at the heart of the disease’s intricacy. Predicting SARS-CoV-2 pathogenicity through laboratory biomarkers and as such, identifying the patients’ illness severity at the time of initial admission would be crucial in aiding patient care. In this study, we sought to evaluate hematological, biochemical and inflammatory biomarkers in COVID-19 patients. This was a cross-sectional research with 48 COVID-19 patients (16 asymptomatic/mild, 16 moderate, and 16 severe) and 48 age-sex matched COVID-19-negative clients from Moi Teaching and Referral Hospital in Kenya. On admission, demographic information, symptoms, and laboratory test results were collected. Significantly, COVID-19 severity was associated with hemoglobin (p<0.0001), white blood cells (p=0.0022), hematocrit (p<0.0001), blood urea nitrogen (p=0.01), blood sodium (p=0.0002), potassium (p=0.0483), C-reactive protein (p=0.0002), and Lactate Dehydrogenase (p<0.0001). CRP showed a high positive connection (0.5433; p=0.0006) with COVID-19 severity, but LDH showed a mild positive correlation (0.2484; p<0.0001). When comparing asymptomatic/mild COVID-19 to severe COVID-19, discriminative accuracy for CRP and LDH was greatest (AUC:0.8867, 95% CI:0.7532-1.000) and (AUC:1.000, 95% CI:1.000-1.000), respectively. Inflammatory biomarkers, hematological and biochemical indices have the potential to complement SARS-CoV-2 testing and predict the course of COVID-19. This will be useful in designing appropriate care for COVID-19 patients through targeted therapy.

8 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
RARebeccah Moraa Ayako
Rebeccah Moraa Ayako
JMJoshua. M. Mutiso
Joshua. M. Mutiso
JMJohn. C. Macharia
John. C. Macharia
DLDavid Langoi
David Langoi
LOLucy Ochola
Lucy Ochola
Malaria and visceral leishmaniasis coexist in the same geographical regions. However, dual co-infection with parasites causing these diseases and their impact on public health is poorly documented. Interactions between these parasites may play a role in disease outcome. The present study set out to evaluate the clinical and immunological parameters following Leishmania donovani and Plasmodium berghei co-infection in BALB/c mice. Mice were divided into four groups; L. donovani- only, L. donovani- P. berghei, P. berghei- only and naïve. Body weight, parasite burden, total IgG, IFN-γ and IL-4 responses were determined. To determine the survival rate, four mice were used from each group. Tissues for histological analysis were taken from spleen, liver and brain. Results indicated significant differences in body weight (P<0.0001), L. donovani parasite load (P< 0.0001 ), L. donovani IgG (P< 0.0001), P. berghei parasitemia (P= 0.0222), P. berghei IgG (P= 0.002), IFN-γ (P<0.0001) and IL-4 (P<0.0001) in dual-infected mice. There was no correlation between L. donovani parasite load and IgG responses in single or dual infections, while there was a positive relationship of P. berghei parasitemia and IgG responses in the dual infection group only. Plasmodium berghei had the highest mortality rate compared to L. donovani - only and L. donovani- P. berghei infected mice groups. Histological analyses showed enlarged red and white pulps and pathological changes in the spleen, liver and brain tissues which were less pronounced in co- infected group. We conclude that L. donovani and P. berghei co-infection reduces disease severity and these changes seem to correlate with variation in serum IgG and cytokines (IFN-γ and IL-4). Therefore, the study recommends the importance of inclusion of early screening of malaria in Visceral Leishmaniasis patients in regions where malaria is co- endemic. Author Summary: Visceral leishmaniasis and malaria are the principal causes of morbidity and mortality affiliated with parasitic diseases universally warranting the necessity to investigate the control and immunology of the infections. Notwithstanding the probable incidences of leishmaniasis- malaria infections in endemic regions are not readily eminent to the clinicians if an individual is co-infected and almost frequently, such patients develop a fever and are customarily treated against malaria and hence the need to study disease progression and outcome during a co- infection. Furthermore, it is unclear if this co-infection could impede the clinical symptoms of the separate diseases and thus the necessity to demonstrate disease outcome in experimentally co-infected murine models. This present study was crucial to find out whether this mode of co- infection alters disease progression and enhanced severity leading to high morbidity and mortality. This current research was an imperative step in using murine as a model in the study of disease outcome and immunopathogenesis of visceral leishmaniasis and malaria co-infection thus establishing the feasibility of co-infecting the BALB/c mice with Leishmania donovani and Plasmodium berghei .

19 May 2025
Verified
Preprint
Open access
RARebeccah Moraa Ayako
Rebeccah Moraa Ayako
RARebeccah M Ayako
Rebeccah M Ayako
KPKirtika Patel
Kirtika Patel
INIsaac Ndede
Isaac Ndede
SMSimeon K Mining
Simeon K Mining
MLMarie Larsson
Marie Larsson
Cellular and humoral responses, as well as virus replication kinetics, may affect the severity of COVID-19. This study examined systemic and mucosal immune responses as well as viral load in unvaccinated SARS-CoV-2 patients. Forty-eight COVID-19-positive, grouped into asymptomatic, moderate and severe disease, and 48 COVID-19-negative individuals at Moi Teaching and Referral Hospital in Kenya were included. Severe patients showed higher viral loads and systemic antispike IgG compared to moderate and asymptomatic individuals. Asymptomatic individuals had higher mucosal anti-spike IgG and receptor binding domain (RBD) levels compared to severe patients. Systemic IFN-α mRNA transcript was expressed at higher levels in asymptomatic individuals compared to patients with severe COVID-19 and healthy individuals. Severe patients had significantly lower expression of IFN-γ mRNA transcript levels in both blood and mucosa, as well as significantly lower systemic IFI-16 mRNA transcript levels. These results suggest that mucosal anti-spike and RBD IgG may offer protection, while systemic antibodies indicate disease progression. Suppressed interferon responses, both mucosal and systemic, were linked to severe disease. To conclude, viral load, IFN, anti-viral, and systemic IgGs could help predict COVID-19 outcomes and aid in developing personalized treatment strategies.

10 October 2025 in Research Square
Verified
Preprint
Open access
PDF file
JNJudith Njeri
Judith Njeri
JMJoshua M Mutiso
Joshua M Mutiso
RARebeccah Moraa Ayako
Rebeccah Moraa Ayako
MGMichael M Gicheru
Michael M Gicheru
Visceral leishmaniasis (VL) is a significant health issue because of limited administration of chemotherapy treatment, being too toxic and even emerging forms of resistance that necessitates to develop new forms of immunotherapeutic treatment. The research compared the adjuvant (vaccination) capacity of Carissa edulis extract combined with soluble Leishmania donovani antigen (SLA) in the BALB/c mice. Eighty BALB/c mice received SLA, C. edulis, combination, or PBS, then challenged with L. donovani; parasite, cytokine, antibodies measured. The highest protection in the mice vaccinated with SLA + C. edulis (4.9%-6.0) was observed, parasite burden which was lower as compared to the SLA + C. edulis (4.9) and also C. edulis (4.9). The biggest cytokine profile accused the best cytokines profile, with significantly higher levels of IFN-γ (217.4 pgmL (p = 0.0110)) as well as postponed levels of IL-10 (35-40 pgmL). The combination group showed robust activation of humoral response given that IgG2a performed as high as (3 mg/mL (p = 0.0245) markedly higher as compared to either treatment, whereas IgG1 increases were smaller and SLA-dependent. It was further ascertained that the level of parasite burden is positively correlated with IL-10 (r = 0.97, p = 0.0061) and IgG1 (r = 0.92, p = 0.0278), but negatively with IgG2a, which supports the protective nature of Th1-related immunities. The results have shown that the extract of C. edulis is synergistically antigenic stimulating the Th1-biased response with increased IFN-γ and IgG2a, and decreased IL-10, as well as enhanced the parasite clearance effect.